{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/heather-jacene/", "hostname": "dana-farber.org", "description": "Heather Jacene, MD - Radiology.", "sitename": "dana-farber.org", "date": "2021-12-22", "cleaned_text": "Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood Adv. 2023 09 12; 7(17):4748-4759. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36399518) Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. PET/CT Image-Based Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer. J Nucl Med Technol. 2023 Jun 14. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37316304) SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy. J Nucl Med. 2023 Jun 08. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37290800) COVID-19: Findings in nuclear medicine from head to Clin Imaging. 2023 Jul; 99:10-18. View Med. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36725249) Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges. J Nucl Med. 2023 03; 64(3):349-350. View in: procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023 04; 50(5):1466-1486. View is associated with shorter survival in adrenocortical carcinoma. Am J Surg. 2023 02; 225(2):309-314. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36137821) Key Factors to Attract More U.S. Diagnostic Radiology Residents into the Field of Nuclear Medicine and Molecular Imaging: A National Survey. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36215645) Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal Ingestion. Dig Dis Sci. 2023 02; 68(2):541-553. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35995883) Med. 2022 09; 52(5):542-550. View in: tumor penetration of BRAF inhibitors using computationally guided combination therapy. Sci Adv. 2022 29; to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers. JAMA Otolaryngol Therapy Cancer: Practicality Current Nucl Med. 2021 Dec; 62(Suppl 3):23S-35S. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34857619) MRI Changes in Breast Skin Following Preoperative Therapy for Patients with Inflammatory Breast Cancer. Acad Radiol. Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. Am J Clin Oncol. Med. 2021 07 01; 68Ga-DOTATATE uptake on with pathologic features of cellular Cancers (Basel). 2021 Jun 06; 13(11). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34204102) Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5a-Dihydrotestosterone A Pilot Lecture: General Nuclear Medicine and Molecular Imaging. J Med. 10; Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32852531) Parameter for J Clin Oncol. 2020 and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Res Treat. 2020 Jun; 181(2):383-390. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32318957) in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31939697) Computed tomographic assessment of lean mass in patients on selective androgen receptor modulator. Clin Imaging. 2019 SNMMI Highlights Lecture: General Nuclear Medicine and Molecular Imaging. J Nucl Med. 2019 Oct; 60(10):13N-18N. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31575717) Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience. Breast J. 2020 03; 26(3):384-390. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31448540) No delayed imaging or CCK administration is needed in most cases when bowel excretion does not occur but gallbladder fills promptly. Ann Nucl Med. 2019 Oct; 33(10):740-745. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31297700) Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial. Eur Cancer. 2019 44(5):414-416. Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade. Clin Breast Cancer. 2019 04; 19(2):146-155. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30584057) 2018 SNMMI Highlights 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division. J Nucl Med Technol. 2018 Sep; Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases. Clin Cancer Res. 2018 09 01; of hyperglycemia Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and 01; 48(1):37-49. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29195616) Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD?\u00d7?two cycles followed Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2017 Sep; 24(9):2563-2569. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28076709) Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy. Blood. 2016 11 24; 128(21):2489-2496. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27574190) Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy. Clin Genitourin Cancer. 2017 04; 15(2):e289-e298. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27651103) Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center. J Am Coll Radiol. 2016 Apr; 13(4):365-71. Extramedullary Correlation of FDG-PET/CT Findings With Nucl Med. 2016 Jan; 41(1):e7-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26252323) Response to Oncol. 2015; 4:30. View breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Res Treat. 2015 May; 151(1):225-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25893587) Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Ann Surg Oncol. 2015 Aug; 22(8):2483-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25791789) Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics. 2015 Mar-Apr; 2015 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25475380) and atypical primary leiomyosarcoma of inferior vena cava in a patient evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings. 9(2):217-35. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25030284) What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach. Radiographics. 2013 follicular lymphoma: a systematic review and meta-analysis. Clin emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center. J Am Acad Dermatol. 68(4):592-599. View in: pathology: a blind spot for radiologists? Part 1, primary pathology. AJR Am J Roentgenol. 199(2):W163-7. View in: for radiologists? Part 2--lymphoma, leukemia, and metastatic disease. lymphoma: favorable of combined modality treatment for patients with non-Hodgkin lymphoma and positive postchemotherapy View in: Molecular imaging training for nuclear medicine residents. J Nucl Med. 2012 Apr; 53(4):655-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22410460) Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood. 2012 May 03; 119(18):4129-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22343727) Molecular training Med. 53(1):16NA. View in: relationship patients' serum glucose levels and metabolically active brown adipose II in classic lymphoma (cHL). J Clin Oncol. 2011 May 20; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21098795) Measuring the \"unmeasurable\": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma. Acad of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med. 2010 Feb; 51(2):246-50. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20124047) Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT. J Nucl reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med. 2009 Nov; 50(11):1760-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19837757) Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2009; 71(5):251-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19776658) The importance of brown adipose tissue. N Engl J Med. 2009 Jul 23; 361(4):417-8; reply 419-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19630142) From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med. 2009 May; 50 Suppl 1:122S-50S. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19403881) Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--patient positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy. J Clin Oncol. 2009 Jun 01; 27(16):2697-704. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19380450) Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake. Med Phys. 2009 Feb; 36(2):612-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19292001) Assessment of the incremental value recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual Nucl Med. 2009 Jan; 50(1):8-17. of FDG PET activity of fibrous dysplasia of the skull late in life mimicking Nucl Med. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19033807) Recurrent or residual hyperparathyroidism and thyroid cancer effectively evaluated with scintigraphy. Otolaryngol Reproducibility of tumor blood with 15O-water J Nucl Med. 2008 Oct; 49(10):1620-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18832120) Diagnosis and differentiation of bronchioloalveolar from adenocarcinoma with bronchioloalveolar components with metabolic and characteristics reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. J Clin Oncol. 2008 Sep 01; 26(25):4172-9. View in: of yttrium ibritumomab tiuxetan (90Y-RIT) with autologous stem cell transplantation or refractory B-cell View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27951111) Comparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--Monte Carlo simulation studies. IEEE 2008 tiuxetan in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17942813) Scalene a head and neck PET/CT. Eur J Nucl Med Mol Imaging. 2008 tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg. 2007 Aug; 11(8):961-9; discussion in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17541799) training residents: on pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. J Nucl Med. 2006 Jun; 47(6):950-6. View in: positron emission and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac. Gynecol Oncol. with FDG PET-CT: case examples and common Jul-Aug; 25(4):1031-43. View "}